Bioequivalence Study of DWZ2501 in Patients With Advanced BRCA-mutated High-grade Ovarian Cancer
Clinical trial NCT07371104 · RECRUITING
Trial details
- NCT number
- NCT07371104
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-22
- Primary completion
- 2027-03-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.